Afatinib

Afatinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-A2077.5 5 mg -

3 - 8 business days*

167.00€
LKT-A2077.10 10 mg -

3 - 8 business days*

257.00€
LKT-A2077.25 25 mg -

3 - 8 business days*

449.00€
LKT-A2077.100 100 mg -

3 - 8 business days*

1,283.00€
 
Afatanib is an anticancer chemotherapeutic compound that has been approved to treat advanced lung... more
Product information "Afatinib"
Afatanib is an anticancer chemotherapeutic compound that has been approved to treat advanced lung cancers such as non-small cell lung cancer (NSCLC) and is in clinical trials as a potential treatment for other advanced solid tumors such as breast cancer and colorectal cancer. Afatanib exerts its anticancer activity through inhibition of EGFR and EGRF2 (HER2/ErbB2). In vivo, afatanib downregulates expression of HER2, increasing apoptosis and decreasing tumor size.
Keywords: BIBW 2992
Supplier: LKT Laboratories
Supplier-Nr: A2077

Properties

Application: EGFR / ErbB2 inhibitor
MW: 485.94 D
Purity: >98%
Format: Solid

Database Information

KEGG ID : K04361 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Signal Word: Danger
GHS Hazard Pictograms:
H Phrases: H300, H315, H318, H361, H373
P Phrases: P201, P202, P260, P264, P270, P280, P281, P314, P321, P330, P301+P310, P302+P352, P305+P351+P338, P308+P313, P332+P313, P337+P313, P362+P364, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Afatinib"
Write a review
or to review a product.
Viewed